As of December 18, 2019, 87 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
As of November 15, 2019, 83 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
On Tuesday, October 15, researchers from MAPS Public Benefit Corporation (MAPS PBC) conducted the official site initiation visit for our new study site location in Santa Fe, New Mexico, for our ongoing …
We are launching a third study location in Santa Fe, New Mexico, for our ongoing therapist training study, which also takes place in Boulder, Colorado, and Charleston, South Carolina. The new study site …
As of August 28, 2019, 81 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
On June 5, 2019, the 79th participant enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this multi-site …
On May 15, 2019, the 76th participant enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this multi-site …
PRESS RELEASE: Psychopharmacology Publishes Combined Analysis of Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD CONTACT: Betty Aldworth, Director of Communications and Events, MAPS Media Requests: …
The MDMA Therapy Training Program has launched a series of trainings to prepare therapy providers to become eligible to work on a MAPS MDMA/PTSD protocol. In January 2019, MAPS PBC submitted an MDMA-assisted …
On April 2, 2019, six United States Senators sent Attorney General William Barr a formal letter to follow-up about pending applications to manufacture marijuana for scientific research. “Our nation’s …
On March 28, 2019, United States Senators Brian Schatz and Cory A. Booker of the Senate Judiciary Committee sent a formal letter to Attorney General William Barr regarding the delay of licensing new manufacturers …
On January 15, 2019, the 73rd participant officially enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
